VanEck Associates
NEO icon

VanEck Associates’s NeoGenomics NEO Stock Holding History

VanEck Associates’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,019
Closed -$30K – 1431
2026
Q1 		$30K Sell
4,019
-902
-18% -$9.49K ﹤0.01% 1351
2025
Q4 		$58K Buy
4,921
+2,619
+114% +$28.3K ﹤0.01% 1350
2025
Q3 		$18K Buy
2,302
+705
+44% +$4.94K ﹤0.01% 1376
2025
Q2 		$12K Buy
1,597
+237
+17% +$1.91K ﹤0.01% 1369
2025
Q1 		$13K Hold
1,360
– – ﹤0.01% 1354
2024
Q4 		$22K Sell
1,360
-364
-21% -$5.65K ﹤0.01% 1336
2024
Q3 		$23K Sell
1,724
-782
-31% -$12.2K ﹤0.01% 1309
2024
Q2 		$35K Hold
2,506
– – ﹤0.01% 1305
2024
Q1 		$39K Buy
2,506
+132
+6% +$2.04K ﹤0.01% 1292
2023
Q4 		$38K Buy
2,374
+402
+20% +$6.58K ﹤0.01% 1302
2023
Q3 		$24K Sell
1,972
-202
-9% -$3K ﹤0.01% 1329
2023
Q2 		$35K Hold
2,174
– – ﹤0.01% 1322
2023
Q1 		$38K Buy
2,174
+125
+6% +$1.78K ﹤0.01% 1322
2022
Q4 		$19K Buy
2,049
+600
+41% +$5.59K ﹤0.01% 1363
2022
Q3 		$12K Buy
+1,449
New +$14.4K ﹤0.01% 1334

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

VanEck Associates's NEO Position: Q2 2026 in Review

VanEck Associates sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 4,019 shares — an estimated $30K sold.

VanEck Associates first reported a position in NEO in Q3 2022 and held it in 15 quarters. The position peaked at $58K in Q4 2025. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • VanEck Associates reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
  • VanEck Associates sold 4,019 NeoGenomics shares in Q2 2026, an estimated $30K.
  • VanEck Associates first reported a position in NeoGenomics in Q3 2022 and held it in 15 quarters.
  • VanEck Associates's NeoGenomics position peaked at $58K in Q4 2025.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.